Abducens Nerve Palsy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal behavior
|
0.310 |
Biomarker
|
phenotype |
BEFREE |
Pretreatment of mice with the pharmacological TRPV4 inhibitor HC067047 prior to paclitaxel injections prevented electrophysiological and behavioral changes associated with paclitaxel-induced neuropathy.
|
29715474 |
2018 |
Abnormal behavior
|
0.310 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Monozygotic twins affected with Kleine-Levin syndrome.
|
22547884 |
2012 |
Abnormal bone formation
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
SMD Kozlowski type caused by p.Arg594His substitution in TRPV4 reveals abnormal ossification and notochordal remnants in discs and vertebrae.
|
28687525 |
2017 |
Abnormal bone formation
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Overexpression of a mutant TRPV4 caused a lethal skeletal dysplasia that phenocopied many abnormalities associated with metatropic dysplasia in humans, including dumbbell-shaped long bones, a small ribcage, abnormalities in the autopod, and abnormal ossification in the vertebrae.
|
24644033 |
2014 |
Abnormal cortical bone morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal enchondral ossification
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormal form of the vertebral bodies
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal metaphyseal vascular invasion
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of epiphysis morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the eye
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the face
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the intervertebral disk
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the metaphysis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the rib cage
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the ribs
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absent primary metaphyseal spongiosa
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acoustic Neuroma
|
0.010 |
Biomarker
|
disease |
BEFREE |
TRPV4 was also present in the endolymphatic sacs of patients with vestibular schwannoma and with Ménière's disease.
|
19066426 |
2009 |
Acquired Kyphoscoliosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Acute cardiac pulmonary edema
|
0.010 |
Biomarker
|
disease |
BEFREE |
Pulmonary capillary endothelial transient receptor potential vanilloid 4 (TRPV4) channel plays a critical role in mediating the development of cardiogenic pulmonary edema.
|
30637626 |
2019 |
Acute Cerebrovascular Accidents
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data indicate that TRPV4 channels may represent a potential target to ameliorate the PID-induced calcium overload of astrocytes and neurons during acute stroke.
|
28639721 |
2017 |
Adult Meningioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The above data support that TRPV1-4 channels are implicated in meningioma pathogenesis, and TRPV4 has predictive significance in the disease.
|
31119368 |
2019 |
Agenesis of corpus callosum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The recognized CMT2 genotypes include: CMT2A (mapped to chromosome 1p35-36); CMT2B (3q13-22); CMT2C (with vocal cord paresis); CMT2D (7p14); CMT2E, related to a mutation in the NF-L gene on chromosome 8p21; proximal CMT2, or HMSN P (3q13.1); CMT2 with MPZ mutations; autosomal recessive CMT2 (1q21.2-q21.3); agenesis of the corpus callosum with sensorimotor neuronopathy (15q13-q15); CMT2 X-linked with deafness and mental retardation (Xq24-q26).
|
11231025 |
2001 |
Akinesia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Although some degree of restriction of movements is not uncommon in fetuses with skeletal dysplasia, akinesia as leading sign is unusual and suggests that certain TRPV4 mutations produce both chondrodysplasia and a peripheral neuropathy resulting in a severe "overlap" phenotype.
|
21964829 |
2011 |